1. Home
  2. KRRO vs SVII Comparison

KRRO vs SVII Comparison

Compare KRRO & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • SVII
  • Stock Information
  • Founded
  • KRRO 2014
  • SVII 2021
  • Country
  • KRRO United States
  • SVII United States
  • Employees
  • KRRO N/A
  • SVII N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • SVII Blank Checks
  • Sector
  • KRRO Health Care
  • SVII Finance
  • Exchange
  • KRRO Nasdaq
  • SVII Nasdaq
  • Market Cap
  • KRRO 147.4M
  • SVII 119.4M
  • IPO Year
  • KRRO 2019
  • SVII 2022
  • Fundamental
  • Price
  • KRRO $30.76
  • SVII $12.05
  • Analyst Decision
  • KRRO Strong Buy
  • SVII
  • Analyst Count
  • KRRO 7
  • SVII 0
  • Target Price
  • KRRO $96.71
  • SVII N/A
  • AVG Volume (30 Days)
  • KRRO 240.6K
  • SVII 23.5K
  • Earning Date
  • KRRO 11-11-2025
  • SVII 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • SVII N/A
  • EPS Growth
  • KRRO N/A
  • SVII N/A
  • EPS
  • KRRO N/A
  • SVII 0.17
  • Revenue
  • KRRO $6,281,000.00
  • SVII N/A
  • Revenue This Year
  • KRRO $97.27
  • SVII N/A
  • Revenue Next Year
  • KRRO N/A
  • SVII N/A
  • P/E Ratio
  • KRRO N/A
  • SVII $72.64
  • Revenue Growth
  • KRRO N/A
  • SVII N/A
  • 52 Week Low
  • KRRO $10.29
  • SVII $11.20
  • 52 Week High
  • KRRO $98.00
  • SVII $12.74
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 64.76
  • SVII 51.87
  • Support Level
  • KRRO $20.20
  • SVII $11.91
  • Resistance Level
  • KRRO $37.03
  • SVII $12.35
  • Average True Range (ATR)
  • KRRO 3.59
  • SVII 0.11
  • MACD
  • KRRO 0.79
  • SVII -0.01
  • Stochastic Oscillator
  • KRRO 64.15
  • SVII 31.84

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About SVII Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp II is a blank check company.

Share on Social Networks: